Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announces that it has entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems, in an all-cash transaction that values Augmedix at approximately $139 million in equity value. Under the terms of the agreement, Augmedix stockholders will receive $2.35 per share in cash upon completion of the proposed transaction, and Augmedix will become a wholly-owned subsidiary of Commure. The purchase price represents a premium of approximately 169% over the volume weighted average price (VWAP) of Augmedix’s common stock for the 30 days ending July 18, 2024.
Read the full article: Augmedix to Join Forces with Commure //
Source: https://www.globenewswire.com/news-release/2024/07/19/2915819/0/en/Augmedix-to-Join-Forces-with-Commure.html